Celldex Therapeutics (CLDX)
Add to Watchlists Create an Alert
12.17
-0.13 -1.06%
NASDAQ
May 24, 12:43PM
BATS Real time
Currency in USD
Celldex Therapeutics Return on Equity:
-53.87% for March 31, 2013Celldex Therapeutics Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -53.87% |
| Dec. 31, 2012 | -64.55% |
| Sept. 30, 2012 | -62.15% |
| June 30, 2012 | -58.35% |
| March 31, 2012 | -58.13% |
| Dec. 31, 2011 | -58.57% |
| Sept. 30, 2011 | -12.86% |
| June 30, 2011 | -9.74% |
| March 31, 2011 | -9.35% |
| Dec. 31, 2010 | -3.84% |
| Sept. 30, 2010 | -75.67% |
| June 30, 2010 | -88.66% |
| March 31, 2010 | -113.4% |
| Dec. 31, 2009 | -172.7% |
| Sept. 30, 2009 | -278.0% |
| June 30, 2009 | -180.1% |
| March 31, 2009 | -148.5% |
| Dec. 31, 2008 | -241.3% |
| Sept. 30, 2008 | -333.6% |
| June 30, 2008 | -603.8% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
CLDX Return on Equity Benchmarks
| Companies | |
|---|---|
| Array BioPharma | |
| Ariad Pharmaceuticals | -103.4% |
| Insmed | -32.34% |
CLDX Return on Equity Rankings
| Overall |
47th percentile 4186 of 8009 |
| Sector |
49th percentile 350 of 687 in Healthcare |
| Industry |
69th percentile 76 of 248 in Biotechnology |
CLDX Return on Equity Range, Past 5 Years
| Minimum | -603.8% | Jun 2008 |
| Maximum | -3.84% | Dec 2010 |
| Average | -131.4% |
